FASENRA SCEI for long-term use

Study identifier:D3250C00057

ClinicalTrials.gov identifier:NCT03588546

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

FASENRA Subcutaneous Injection 30 mg Syringe Specific Clinical Experience Investigation for long-term use

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

653

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 31 May 2018
Estimated Primary Completion Date: 30 Apr 2025
Estimated Study Completion Date: 30 Apr 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2023 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria